SkinBioTherapeutics PLC - ESG Rating & Company Profile powered by AI
Full Sustainability assessment of SkinBioTherapeutics PLC can be reached by registering for free. If you are employed by SkinBioTherapeutics PLC and you would like to use your Sustainability rating, please contact us. The webpage contains a zero-cost ESG report covering SkinBioTherapeutics PLC.
SkinBioTherapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 8.0, social score of 4.8 and governance score of 4.0.
5.6
Medium ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1734711026341)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
579 | VIVA Biotech Holdings | 5.7 | High |
602 | SkinBioTherapeutics PLC | 5.6 | High |
602 | Celltrion Inc | 5.6 | High |
602 | Adaptimmune Therapeutics PLC | 5.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1734711026341)
Frequently Asked Questions
Does SkinBioTherapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Does SkinBioTherapeutics PLC disclose current and historical energy intensity?
Does SkinBioTherapeutics PLC report the average age of the workforce?
Does SkinBioTherapeutics PLC reference operational or capital allocation in relation to climate change?
Does SkinBioTherapeutics PLC disclose its ethnicity pay gap?
Does SkinBioTherapeutics PLC disclose cybersecurity risks?
Does SkinBioTherapeutics PLC offer flexible work?
Does SkinBioTherapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does SkinBioTherapeutics PLC disclose the number of employees in R&D functions?
Does SkinBioTherapeutics PLC conduct supply chain audits?
Does SkinBioTherapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does SkinBioTherapeutics PLC conduct 360 degree staff reviews?
Does SkinBioTherapeutics PLC disclose the individual responsible for D&I?
Does SkinBioTherapeutics PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does SkinBioTherapeutics PLC disclose current and / or historical scope 2 emissions?
Does SkinBioTherapeutics PLC disclose water use targets?
Does SkinBioTherapeutics PLC have careers partnerships with academic institutions?
Did SkinBioTherapeutics PLC have a product recall in the last two years?
Does SkinBioTherapeutics PLC disclose incidents of discrimination?
Does SkinBioTherapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Has SkinBioTherapeutics PLC issued a profit warning in the past 24 months?
Does SkinBioTherapeutics PLC disclose parental leave metrics?
Does SkinBioTherapeutics PLC disclose climate scenario or pathway analysis?
Does SkinBioTherapeutics PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does SkinBioTherapeutics PLC disclose the pay ratio of women to men?
Does SkinBioTherapeutics PLC support suppliers with sustainability related research and development?
Does SkinBioTherapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does SkinBioTherapeutics PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is SkinBioTherapeutics PLC involved in embryonic stem cell research?
Does SkinBioTherapeutics PLC disclose GHG and Air Emissions intensity?
Does SkinBioTherapeutics PLC disclose its waste policy?
Does SkinBioTherapeutics PLC report according to TCFD requirements?
Does SkinBioTherapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does SkinBioTherapeutics PLC disclose energy use targets?
Does SkinBioTherapeutics PLC disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does SkinBioTherapeutics PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for SkinBioTherapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
SkinBioTherapeutics plc, a life science company, engages in the research and development of technology that harnesses the human microbiome to improve health. The company develops SkinBiotix technology that can enhance the barrier effect of skin models, protect skin from infections, and repair wounds; and AxisBiotix that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company has a collaboration agreement with Croda Plc; the University of Manchester to develop immune-supporting microbiome formulations; and Winclove Probiotics B.V. for the development of a probiotic blend of good bacterial strains based on the modifying properties of specific bacterial species in known psoriasis pathways. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.